Skip to main content
Go to the home page of the European Commission (opens in new window)
English English
CORDIS - EU research results
CORDIS

Implementing oral and long acting Pre-exposure prophylaxis in mobile men in Sub-Saharan Africa [MOBILE MEN]

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Deliverables

Rapid assessment report (opens in new window)

Determine barriers and motivators towards uptake of on-demand and injectable PrEP

Dissemination and exploitation plan (opens in new window)
Report of roles (opens in new window)

Confirmation of leadership and mentorship roles

Capacity strengthening plan (opens in new window)
Study initiation package (opens in new window)

Registration number of the clinical study in a registry meeting WHO Registry criteria. Final version of study protocol as approved by the regulator(s) / ethics committee(s). Regulatory and ethics (if applicable, institutional) approvals required for the enrolment of the first study participant.

Rapid assessment and other qualitative data collection (opens in new window)

Characteristics of men willing to take oral versus injectable PrEP

Draft stewardship plan (opens in new window)

Beneficiaries must prepare stewardship plans outlining how to achieve the optimal use of an intervention, including, for example, how to avoid irrational use, overuse or abuse of health technologies (e.g. antimicrobials). A draft plan must be submitted after half the duration of the project has elapsed and a final plan must be submitted with the final report.

Midterm recruitment report (opens in new window)

Midterm recruitment report. This report is due when 50% of the study population is recruited. The report shall include an overview of the number of recruited participants by clinical sites, any problems in recruitment and, if applicable, a detailed description of implemented and planned measures to compensate for any incurred delays. The Global Health EDCTP3 Joint Undertaking reserves the right to terminate the MOBILE MEN project if milestone MS16 has not been achieved and by month 18 no clinical trial participant has received long-acting cabotegravir.

Rapid assessment (opens in new window)

Characterize mobile men at risk of HIV

Consortium meeting (opens in new window)

Kick-off meeting and confirmation of committees

Searching for OpenAIRE data...

There was an error trying to search data from OpenAIRE

No results available

My booklet 0 0